Cellnovo Group (“Cellnovo” CLNV:EN Paris), a medical technology company marketing the first mobile, connected, all-in-one diabetes management system, announces that its first industrialisation milestone with Flex has been reached. This is consistent with the manufacturing transfer plan, announced last year, that will bring an increase in the production capacity of Cellnovo’s diabetes management system in the second part of 2016.
Cellnovo began transferring the manufacturing of its disposable insulin cartridges to Flex in Q3 2015 and is benefitting from Flex’s industry-leading experience in automation and manufacturing of medical devices.